Modern diuretic therapy;Moderne differenzialtherapie mit diuretika

Internist

Volumn 45, Issue 5, 2004, Pages 598-605

  Fliser, D ^a   Haller, H ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Heart failure; Hypertension; Loop diuretics; Renal failure; Thiazides

Indexed keywords

ACETAZOLAMIDE; AMILORIDE PLUS HYDROCHLOROTHIAZIDE; BUMETANIDE; BUTIZIDE; CHLORTALIDONE; DIURETIC AGENT; ETACRYNIC ACID; FURO ALDOPUR; FUROSEMIDE; FUROSEMIDE PLUS SPIRONOLACTONE; HYDROCHLOROTHIAZIDE; HYDROCHLOROTHIAZIDE PLUS SPIRONOLACTONE; HYDROCHLOROTHIAZIDE PLUS TRIAMTERENE; INDAPAMIDE; METOLAZONE; MODURETIK; NATRILIX SR; PIRETANIDE; SPIRONOLACTONE; TORASEMIDE; TRIAMTERENE PLUS XIPAMIDE; UNCLASSIFIED DRUG; XIPAMIDE;

DIURETIC ACTIVITY; DIURETIC THERAPY; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG MIXTURE; DRUG SAFETY; EDEMA; FLUID BALANCE; GASTROINTESTINAL SYMPTOM; GYNECOMASTIA; HEART FAILURE; HUMAN; HYPERCALCEMIA; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; HYPOKALEMIA; HYPOMAGNESEMIA; HYPONATREMIA; HYPOVOLEMIA; METABOLIC ACIDOSIS; NEPHRON; OTOTOXICITY; PATHOPHYSIOLOGY; REVIEW; SODIUM ABSORPTION;

ALDOSTERONE ANTAGONISTS; BENZOTHIADIAZINES; DIURETICS; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTENSION; HYPERTENSION, RENAL; PATIENT CARE MANAGEMENT; PHYSICIAN'S PRACTICE PATTERNS; SODIUM CHLORIDE SYMPORTER INHIBITORS; TREATMENT OUTCOME;

EID: 2942596170     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00108-003-1118-y     Document Type: Review

References (25)

1. Ellison DH (1994) Diuretic drugs and the treatment of edema: from clinic to bench and back again. Am J Kidney Dis 23: 623-643
2. Brater DC (1998) Diuretic therapy. N Engl J Med 339: 387-395
3. World Health Organization - International Society of Hypertension (1999) Guidelines for the management of hypertension. J Hypertens 17: 151-183
4. Deutsche Hochdruckliga, Deutsche Hypertonie Gesellschaft (2001) Empfehlungen zur Hochdruckbehandlung, 16. Aufl.
5. Almeshari K, Ahlstrom NG, Capraro FE, Wilcox CS (1993) A volume-independent component to postdiuretic sodium retention in humans. J Am Soc Nephrol 3: 1878-1883
6. Wilcox CS, Mitch WE, Kelly RA et al (1983) Response of the kidney to furosemide I: effects of salt intake and renal compensation. J Lab Clin Med 102: 450-458
7. Ferguson JA, Sundblad KJ, Becker PK et al (1997) Role of duration of diuretic effect in preventing sodium retention. Clin Pharmacol Ther 62: 203-208
8. Psaty BM, Smith NL, Siscovick DS et al (1997) Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA 277: 739-745
9. Siscovick DS, Raghunathan TE, Psaty BM et al (1994) Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med 330: 1852-1857
10. Wilcox CS (2002) New insights into diuretic use in patients with chronic renal disease. J Am Soc Nephrol 13: 798-805
11. Rabelink TJ, Bijlsma JA, Koomans HA (1993) Iso-osmotic volume expansion in the nephrotic syndrome. Clin Sci 84: 1-6
12. Chalasani N, Gorski JC, Horlander JC et al. (2001) Effects of albumin/furosemide mixtures on responses to furosemide in hypoalbuminemic patients. J Am Soc Nephrol 12: 1010-1016
13. Akcicek F, Yalniz T, Basci A et al. (1995) Diuretic effects of furosemide in patients with nephrotic syndrome: is it potentiated by intravenous albumin? BMJ 310: 162-163
14. Fliser D, Zurbrüggen I, Mutschler E et al. (1999) Coadministration of albumin and furosemide in patients with the nephrotic syndrome. Kidney Int 55: 629-634
15. Remme WJ, Swedberg K (2001) Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of heart failure. Eur Heart J 22: 1527-1560
16. Hope UC, Erdmann E für die Kommission Klinische Kardiologie der Deutschen Gesellschaft für Kardiologie-Herzund Kreislaufforschung (2001) Leitlinien zur Therapie der chronischen Herzinsuffizienz. Z Kardiol 90: 218-237
17. Cosin J, Diez J, on behalf of the TORIC investigators (2002) Torasemide in chronic heart failure: results of the TORIC study. Eur J Heart Failure 4: 507-513
18. Pitt B, Zannad F, Remme WJ et al. (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341: 709-717
19. Pitt B, Remme W, Zannad F et al.; Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators (2003) Eplerenone, a selective aldosterone blocker, in patients with left ventricle dysfunction after myocardial infarction. N Engl J Med 348: 1309-1321
20. Walma EP, Hoes AW, van Dooren C et al. (1997) Withdrawal of long-term diuretic medication in elderly patients: a double blind randomised trial. BMJ 315: 464-468
21. Rudy DW, Voelker JR, Green PK et al. (1991) Loop diuretics for chronic renal insufficiency: a continous infusion is more potent than bolus therapy. Ann Intern Med 115: 360-366
22. Kaissling B, Stanton BA (1988) Adaption of distal tubule and collecting duct to increased sodium delivery. I. Ultrastructure. Am J Physiol 255: F1256-1268
23. Loon NR, Wilcox CS, Unwin RJ (1989) Mechanism of impaired natriuretic response to furosemide during prolonged therapy. Kidney Int 36: 682-689
24. Ellison DH (1991) The physiological basis of diuretic synergism: its role in treating diuretic resistance. Ann Intern Med 114: 886-894
25. Fliser D, Schröter M, Neubeck M, Ritz E (1994) Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failure. Kidney Int 46: 482-488